Format

Send to

Choose Destination
Curr Opin Immunol. 1996 Oct;8(5):664-9.

Recombinant Listeria monocytogenes cancer vaccines.

Author information

1
Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia 19104, USA. yvonne@mail.med.upenn.edu

Abstract

Listeria monocytogenes has recently been exploited as a vector for targeting antigens to the immune system. In the past year it has been shown to be particularly effective as a tumor antigen vector. Here we set its potency as a cancer vaccine in the context of the type of immunity induced by this facultative intracellular bacterium.

PMID:
8902392
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center